[Behavior of serum lipids, blood coagulation factors, platelet aggregation, complement and serum immunoglobulins in a group of arteriosclerotic, hyperlipemic subjects treated with 3GS].
D000328:Adult; D000368:Aged; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy*; D001779:Blood Coagulation Factors / Q000032:analysis*; D003165:Complement System Proteins / Q000032:analysis*; D005260:Female; D006025:Glycosaminoglycans / Q000627:therapeutic use*; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000097:blood / Q000188:drug therapy*; D006953:Hyperlipoproteinemia Type IV / Q000097:blood / Q000188:drug therapy*; D007136:Immunoglobulins / Q000032:analysis*; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects*
D001779:Blood Coagulation Factors; D006025:Glycosaminoglycans; D007136:Immunoglobulins; D008055:Lipids; C007858:glucuronyl glucosamine glycan sulfate; D003165:Complement System Proteins
Comportamento dei lipidi sierici, dei fattori emocoagulativi, dell'aggregazione piastrinica, del complemento e delle immunoglobuline sieriche in un gruppo di soggetti arteriosclerotici, dislipidemici, trattati con 3GS.